Early stage cirrhosis is relatively mild and the degree of liver function abnormality is relatively mild, and most patients have a survival period of about 5-10 years, which varies somewhat depending on each individual’s condition. In patients who do not pay attention to control, the survival period tends to be shorter, usually ranging from 5-10 years. Therefore, it is important to pay attention to prevention, active liver protection and regular medical checkups. Anti-inflammatory treatment needs to be given in case of abnormal liver function, and drugs such as dicyclomine, silymarin, polyenylphosphatidylcholine, reduced glutathione, adenosylmethionine butadisulfate, etc. can be chosen for anti-inflammatory and liver-protective treatment. It is also important to find the cause of cirrhosis, and treatment for the cause is also a more critical measure.